Breast Cancer Surgeon Houston
Darlene M. Miltenburg MD, FRCS(C), FACS
Dr. Miltenburg is a highly sought after surgeon specializing in the treatment of breast cancer and other diseases of the breast.
Dr. Miltenburg Specializes in
- Consultation for breast cancer, abnormal mammogram any breast problem
- Second opinions
- Breast cancer risk assessment, genetic testing (BRCA, panel testing)
- Breast cancer risk reduction; close monitoring of high-risk patients
- Breast conservation surgery: lumpectomy, sentinel lymph node biopsy
- Oncoplastic surgery
- Skin and nipple sparing mastectomy
- Breast reconstruction
- Nipple ductoscopy for nipple discharge
- Close coordination with plastic surgeons, medical oncologists,
radiation oncologists, physical therapists to ensure comprehensive evaluation and treatment
- Participation in multidisciplinary breast tumor conferences
- Participation in clinical research trials
PREVENTION DIAGNOSIS TREATMENT
The breast tissue in young women is very dense and sensitive to hormones. That’s why breasts can be painful and tender, especially around the time of menstruation. Benign breast masses such as fibroadenomas are common in young women.
Breast feeding can cause mastitis in up to 40% of mothers and can progress to abscess formation. However, there is no evidence that breast infection is associated with breast cancer. In fact, breast feeding is felt to provide some protection from developing breast cancer in the future.
Breast augmentation is not associated with a higher risk of breast cancer. Women in this age group should have early mammograms. The technique is modified when implants are present, but screening mammography has been shown to lower the death rate from breast cancer in this group of women.
After menopause, breast tissue begins to become replaced with fat. Hormone replacement therapy can stop this natural process. Fatty-replaced breasts are less likely to develop cancer and are easier to detect mammographically than dense breasts.
The median age of breast cancer diagnosis in the U.S. is 62.Most cancers in this age group are ER positive. Breast cancer survival has improved the most in postmenopausal Caucasian women with ER positive tumors.
The effectiveness of chemotherapy declines with age. However, the Aromatase Inhibitors (AIs) are very effective in post-menopausal women with ER positive tumors. AIs can also be used to shrink large tumors, making patients eligible for smaller operations such as breast conservation surgery.
Women over age 80 are more likely to be diagnosed with advanced / late stage breast cancer than women aged 50 to 69. Octogenarians are less likely to receive chemotherapy or radiation therapy. Surgery, which has the greatest impact on breast cancer survival, is given to less than half of women over age 80.
Dr. Miltonburg is a great surgeon!!! She has a great personality!!!!! She told me exactly what to expect from her from the cancer and started me on the road to recovery. I love Dr. Miltonburg!!!!!
Dr. Darlene Miltenburg is a great Doctor. She is very professional and knowledgeable. She has been God sent as she cared for my wife. She is also one of the Leaders in her field. She takes the time with her patients. I would highly recommend her, if you want a Doctor who care about patients.